Drug Type Trispecific T-cell engager (TriTE) |
Synonyms |
Target |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD3 modulators(T cell surface glycoprotein CD3 modulators), PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | CH | - |